Biogen Inc. buy UBS Group AG
Start price
08.11.23
/
50%
€216.40
Target price
08.11.24
€291.35
Performance (%)
-25.00%
End price
09.11.24
€162.30
Summary
This prediction ended on 09.11.24 with a price of €162.30. The prediction for Biogen Inc. disappointed with a performance of -25.00%. UBS_Group_AG has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 6.158% | 6.158% | 56.004% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $327.00 to $312.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten